Search research articles
Contact Us
Filters
Showing results (41-50 of 89) with videos related to
Page
of 9
Sort By:
AIDS Research and Treatment
|
October 4, 2024
A Characterization of Women Living with HIV in Belgium
Rakan Nasreddine, Jean Cyr Yombi, Gilles Darcis, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
October 11, 2024
<i>Mycobacterium heraklionense</i>: An emerging cause of hand tenosynovitis
Majdouline El Moussaoui, Nicolas Lambert, Patrick Massage, et al.
AIDS Research and Therapy
|
July 17, 2021
Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020
Nadine Mayasi Ngongo, Hippolyte Situakibanza Nani-Tuma, Marcel Mbula Mambimbi, et al.
BMC Infectious Diseases
|
July 9, 2017
Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy
Gilles Darcis, Gert Van der Auwera, Jean-Baptiste Giot, et al.
Scientific Reports
|
June 7, 2018
Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017
Gilles Darcis, Iseult Lambert, Anne-Sophie Sauvage, et al.
AIDS (London, England)
|
October 19, 2016
Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir
Gilles Darcis, Sophie Bouchat, Anna Kula, et al.
Cell Reports
|
February 21, 2020
CD32<sup>+</sup>CD4<sup>+</sup> T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency
Gilles Darcis, Neeltje A Kootstra, Berend Hooibrink, et al.
Plos One
|
May 16, 2025
Removing barriers to COVID-19 vaccine intention in a university population: Results of a serial mediation study through the dimensions of the Health Belief Model
Marine Paridans, Nadia Dardenne, Nicolas Gillain, et al.
BMC Infectious Diseases
|
September 7, 2021
Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV
Pierre-Emmanuel Plum, Nathalie Maes, Anne-Sophie Sauvage, et al.
Antimicrobial Agents and Chemotherapy
|
December 11, 2019
Detectability of HIV Residual Viremia despite Therapy Is Highly Associated with Treatment with a Protease Inhibitor-Based Combination Antiretroviral Therapy
Gilles Darcis, Nathalie Maes, Alexander O Pasternak, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 89) with videos related to
Sort By:
Page
of 9
AIDS Research and Treatment
|
October 4, 2024
A Characterization of Women Living with HIV in Belgium
Rakan Nasreddine, Jean Cyr Yombi, Gilles Darcis, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
October 11, 2024
<i>Mycobacterium heraklionense</i>: An emerging cause of hand tenosynovitis
Majdouline El Moussaoui, Nicolas Lambert, Patrick Massage, et al.
AIDS Research and Therapy
|
July 17, 2021
Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020
Nadine Mayasi Ngongo, Hippolyte Situakibanza Nani-Tuma, Marcel Mbula Mambimbi, et al.
BMC Infectious Diseases
|
July 9, 2017
Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy
Gilles Darcis, Gert Van der Auwera, Jean-Baptiste Giot, et al.
Scientific Reports
|
June 7, 2018
Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017
Gilles Darcis, Iseult Lambert, Anne-Sophie Sauvage, et al.
AIDS (London, England)
|
October 19, 2016
Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir
Gilles Darcis, Sophie Bouchat, Anna Kula, et al.
Cell Reports
|
February 21, 2020
CD32<sup>+</sup>CD4<sup>+</sup> T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency
Gilles Darcis, Neeltje A Kootstra, Berend Hooibrink, et al.
Plos One
|
May 16, 2025
Removing barriers to COVID-19 vaccine intention in a university population: Results of a serial mediation study through the dimensions of the Health Belief Model
Marine Paridans, Nadia Dardenne, Nicolas Gillain, et al.
BMC Infectious Diseases
|
September 7, 2021
Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV
Pierre-Emmanuel Plum, Nathalie Maes, Anne-Sophie Sauvage, et al.
Antimicrobial Agents and Chemotherapy
|
December 11, 2019
Detectability of HIV Residual Viremia despite Therapy Is Highly Associated with Treatment with a Protease Inhibitor-Based Combination Antiretroviral Therapy
Gilles Darcis, Nathalie Maes, Alexander O Pasternak, et al.
Page
of 9